MYD88 is a downstream mediator following Toll-like receptor activation, the mRNA of which was reported to be over-expressed in CD34+ cells of low-risk MDS compared to healthy donors in previous investigation, inhibition of which restored erythroid colony formatting capacity of HSPC. Here, CD34 is linked to myelodysplastic syndrome.